2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (2) , 271-280
- https://doi.org/10.1016/0006-2952(88)90729-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluidsBiochemical Journal, 1986
- Metal ions and oxygen radical reactions in human inflammatory joint diseasePhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1985
- The importance of free radicals and catalytic metal ions in human diseasesMolecular Aspects of Medicine, 1985
- PLASMA AND SYNOVIAL-FLUID CONCENTRATIONS OF SALICYLIC-ACID AND ITS METABOLITES IN PATIENTS WITH JOINT EFFUSIONS1985
- Antiinflammatory drugs: Protection of a bacterial virus as an in vitro biological measure of free radical activityChemico-Biological Interactions, 1983
- Determination of acetylsalicyclic acid and metabolites in biological fluids by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Determination of aspirin and its major metabolites in plasma by high-performance liquid chromatography without solvent extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Increased Serum Salicylate Metabolites with Age in Patients Receiving Chronic Acetylsalicylic Acid TherapyGerontology, 1981
- Inhibition of Membrane Peroxidation in Thalassaemic Erythrocytes by 2,3‐Dihydroxybenzoic AcidBritish Journal of Haematology, 1976
- SALICYLATE METABOLISM IN MANAnnals of the New York Academy of Sciences, 1971